← Back to Search

Telehealth Support for HIV

Q: To what demographic are participants in this trial limited?

<p>Eligibility requirements for this trial include being <a href="https://www.withpower.com/clinical-trials/hiv">HIV</a>-positive and between 18 to 29 years old. The study is enrolling up to 60 candidates.</p>

N/A

Recruiting

Led By Sophia A. Hussen, MD, MPH

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0, 2, 4, 6, 8* months

Awards & highlights

Study Summary

This trial will assess a program to help young men living with HIV in online delivery to improve social connections and their health. It has 3 phases, engaging a community, a randomized clinical trial, and evaluation. Participants will meet with a study team and provide consent.

Who is the study for?

This trial is for young Black men, including transgender men, aged 18-29 living with HIV in the Atlanta area. Participants must identify as gay or bisexual or have a history of sex with men and be able to meet weekly online for six weeks.Check my eligibility

What is being tested?

The study tests an online group program designed to improve social connections and health outcomes for young men with HIV. It involves adapting the program for telehealth delivery, randomizing participants into immediate or delayed intervention groups, and evaluating it for community use.See study design

What are the potential side effects?

Since this is a behavioral intervention delivered via telehealth focusing on social support rather than medication, there are no direct medical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0, 2, 4, 6, 8* months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0, 2, 4, 6, 8* months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 2, 4, 6, 8* months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Change in Recruitment Rates

Change in retention

+3 more

Secondary outcome measures

Change in Perception of HIV stigma

Change in Perception of Structural Racism and Discrimination.

Change in Perception of discrimination

+12 more

Other outcome measures

Changes in HIV viral load

Rate of retention care

Trial Design

2Treatment groups

Experimental Treatment

Group I: Wait-list control -delayed interventionExperimental Treatment1 Intervention

Await-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period.

Group II: Tele-B6Experimental Treatment1 Intervention

The tele-B6 intervention includes six group sessions delivered over the course of six weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH

2,786 Previous Clinical Trials

2,689,649 Total Patients Enrolled

Emory UniversityLead Sponsor

1,640 Previous Clinical Trials

2,560,597 Total Patients Enrolled

Sophia A. Hussen, MD, MPHPrincipal InvestigatorEmory University

Media Library

Tele-B6 Clinical Trial Eligibility Overview. Trial Name: NCT05829759 — N/A

HIV Research Study Groups: Wait-list control -delayed intervention, Tele-B6

HIV Clinical Trial 2023: Tele-B6 Highlights & Side Effects. Trial Name: NCT05829759 — N/A

Tele-B6 2023 Treatment Timeline for Medical Study. Trial Name: NCT05829759 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants of at least twenty years old viable for this investigation?

"The age range for this study is between 18 and 29 years old."

Answered by AI

To what demographic are participants in this trial limited?

"Eligibility requirements for this trial include being HIV-positive and between 18 to 29 years old. The study is enrolling up to 60 candidates."

Answered by AI

Are persons currently being enrolled in this clinical research?

"Unfortunately, the information on clinicialtrials.gov indicates that this clinical trial is not presently accepting participants. The investigation was initially posted in April 1st 2023, and last updated shortly after on April 13th of the same year; however, there are 18 other studies actively recruiting patients at present."

Answered by AI

What are the aims of this medical research endeavor?

"The principal outcome of this clinical trial, evaluated during the Study Exit period (up to 8 months for waitlist control participants), is a Change in Acceptability Surveys. Other secondary outcomes include an assessment on Everyday Discrimination Scale, HIV Stigma Scale and Internalized Homonegativity Inventory. Each response will receive a value on either the Likert or 5-point scale with scores ranging from 10 to 60 points respectively; higher values may indicate more extreme perceptions."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Telehealth Delivery (Tele-B6)

Sophia Hussen 2023. "Telehealth Delivery (Tele-B6)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05829759.

All > Hiv